BINEX Co., Ltd. (053030.KQ) KOE
Currency In KRW
- General
- Statistics
- Historical Data
- Profile
- Financials
BINEX Co., Ltd.
Address
7-48 SongDo-Dong
Incheon, 406-840
Korea (the Republic of)
Phone
+82 51 260 1300 |
Website
Sector
Healthcare
Industry
Biotechnology
Employees
553
First IPO Date
August 07, 2001
Key Executives
| Name | Title | Pay | Year Born |
| Jung-Tak Moon | Chief Executive Officer | 0 | 1966 |
| Byung-In Lee | Head of Bus. Operation Division and Director | 0 | 1965 |
| Doo-Hyun Kim | Vice President | 0 | 1952 |
| Jung-Jin Lee | Head of Bio-Tech Research Center and Director | 0 | 1964 |
| Hyuk-Jong Lee | Managing Director | 0 | 1969 |
| Myung-Cheol Lee | Managing Director | 0 | 1958 |
| Soo-Yong Jin | Managing Director | 0 | 1968 |
| Won-Seok Kim | Head of Production Division and Director | 0 | 1963 |
| Young-Cheol Son | Head of Management Support Division and Director | 0 | 1964 |
| Jung-Won Seo | Head of Bio Processing Division and Director | 0 | 1962 |
Description
BINEX Co., Ltd. operates as a pharmaceutical enterprise based in South Korea. The company provides an extensive array of medicinal products, encompassing bisroot items, gastrointestinal treatments (including antispasmodics and antiulcerants), NSAIDs, cardiovascular and urology medications, hepatic protective agents, topical ointments and creams, ophthalmic solutions, CNS agents, digestive aids, remedies for constipation and circulation, antibiotics and antifungals, cough and cold preparations, vitamins and nutritional supplements, antihistamines, antivertigo agents, and over-the-counter (OTC) drugs. Additionally, BINEX Co., Ltd. maintains a co-development alliance with Genexine, Inc. focused on the creation of a COVID-19 vaccine. Founded in 1957, its headquarters are situated in Incheon, South Korea.
